New liquid biopsy method offers avenue to quick, affordable cancer diagnosis
Peer-Reviewed Publication
Updates every hour. Last Updated: 26-Apr-2025 01:08 ET (26-Apr-2025 05:08 GMT/UTC)
Researchers from the Josep Carreras Leukaemia Research Institute have found that the efficacy of varni-cel, a CAR-T infusion product for B-ALL patients, is highly dependent on intrinsic features of the CAR-T cells themselves and their progression within the patient. In a recent study published at Cell Reports Medicine, the team identified three key success markers: the CD4:CD8 ratio, exhaustion signals and the expansion of gamma-delta cytotoxic T-cells. Taken together, the results may help reaching higher complete remission rates and sustained disease-free survival in the near future.
University of Calgary study reveals new insights that could help in the diagnosis and treatment of invasive skin cancers, like Marjolin’s ulcer (MU), that grow on chronic burn wounds. The research team completed a cell-by-cell analysis to better understand how MU tumours grow. Using both single cell RNA sequencing and spatial transcriptomics provided precise mapping of gene expression and cellular interactions within tumor tissue sections. With that enhanced view the researchers discovered that a subset of the dermal fibroblasts residing within the tumor, appeared to have come from keratinocytes that typically comprise the outer layer of the skin called epidermis. Findings are published in the Journal of Investigative Dermatology.